Three Seattle biotech companies are joining forces to support open-access development of protein folding and design software.
The project, called OpenFold, brings together Cyrus Biotechnology, Outpace Bio, and Arzeda, startups developing new proteins that can be used as drugs or in industrial applications.
“It doesn’t make sense for all of us to replicate the same work,” Cyrus CEO Lucas Nivon told GeekWire. “Especially if it doesn’t give any one company a competitive advantage.”
Comments are closed.